These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29165510)

  • 1. [The 1,3-β-d-glucan in critical adult patients as diagnostic tool for invasive Candida spp. infection, performance evaluation].
    Donato L; González T; Canales M; Legarraga P; García P; Rabagliati R
    Rev Chilena Infectol; 2017 Aug; 34(4):340-346. PubMed ID: 29165510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis.
    Nguyen MH; Wissel MC; Shields RK; Salomoni MA; Hao B; Press EG; Shields RM; Cheng S; Mitsani D; Vadnerkar A; Silveira FP; Kleiboeker SB; Clancy CJ
    Clin Infect Dis; 2012 May; 54(9):1240-8. PubMed ID: 22431804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
    Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
    Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
    Guo J; Wu Y; Lai W; Lu W; Mu X
    BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis.
    Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y
    Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of (1,3)-beta-D-glucan to diagnosis of invasive candidiasis after liver transplantation.
    Levesque E; El Anbassi S; Sitterle E; Foulet F; Merle JC; Botterel F
    J Clin Microbiol; 2015 Mar; 53(3):771-6. PubMed ID: 25520448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
    Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
    J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
    Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic value of serial (1,3)-β-D-glucan measurements in ICU patients with invasive candidiasis.
    Carelli S; Posteraro B; Torelli R; De Carolis E; Vallecoccia MS; Xhemalaj R; Cutuli SL; Tanzarella ES; Dell'Anna AM; Lombardi G; Cammarota F; Caroli A; Grieco DL; Sanguinetti M; Antonelli M; De Pascale G
    Crit Care; 2024 Jul; 28(1):236. PubMed ID: 38997712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia.
    White PL; Price JS; Posso RB; Barnes RA
    Med Mycol; 2017 Nov; 55(8):843-850. PubMed ID: 28340117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The added value of (1,3)-β-D-glucan for the diagnosis of Invasive Candidiasis in ICU patients: a prospective cohort study.
    Christner M; Abdennadher B; Wichmann D; Kluge S; Pepić A; Aepfelbacher M; Rohde H; Olearo F
    Infection; 2024 Feb; 52(1):73-81. PubMed ID: 37322388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Three β-Glucan Tests for the Diagnosis of Invasive Candidiasis in Intensive Care Units.
    Kritikos A; Caruana G; Poissy J; Mamin A; Bachmann D; Pagani JL; Coste AT; Lamoth F
    J Clin Microbiol; 2023 Feb; 61(2):e0169122. PubMed ID: 36700626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of (1→3)-β-D-glucan in same-day urine and serum samples obtained from patients with haematological malignancies.
    Raggam RB; Fischbach LM; Prattes J; Duettmann W; Eigl S; Reischies F; Wölfler A; Rabensteiner J; Prueller F; Krause R; Hoenigl M
    Mycoses; 2015 Jul; 58(7):394-8. PubMed ID: 25959065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study.
    Mikulska M; Furfaro E; Magnasco L; Codda G; Giacobbe DR; Dentone C; Vena A; Marchese A; Bassetti M
    Clin Microbiol Infect; 2022 Aug; 28(8):1154.e1-1154.e3. PubMed ID: 35283316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis.
    Cohen JF; Ouziel A; Matczak S; Brice J; Spijker R; Lortholary O; Bougnoux ME; Toubiana J
    Clin Microbiol Infect; 2020 Mar; 26(3):291-298. PubMed ID: 31539634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.